Zobrazeno 1 - 10
of 133
pro vyhledávání: '"Hanna, Berak"'
Autor:
Anna Maria Kochanowicz, Sylwia Osuch, Hanna Berak, Aleksandra Kumorek, Kamila Caraballo Cortés
Publikováno v:
Cells, Vol 12, Iss 10, p 1446 (2023)
In chronic hepatitis C (CHC), characterized by exhaustion of T-cell function, increased frequencies of double-positive (DP) (CD4+CD8+) cells are present in peripheral blood. We compared the exhaustion phenotype between DP and single positive (SP) T-c
Externí odkaz:
https://doaj.org/article/6f6ef1d40d2b4437b5eea93d0a1b443d
Autor:
Sylwia Osuch, Tomasz Laskus, Karol Perlejewski, Hanna Berak, Iwona Bukowska-Ośko, Agnieszka Pollak, Magdalena Zielenkiewicz, Marek Radkowski, Kamila Caraballo Cortés
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Background and AimsDuring chronic hepatitis C virus (HCV) infection, CD8+ T-cells become functionally exhausted, undergoing progressive phenotypic changes, i.e., overexpression of “inhibitory” molecules such as PD-1 (programmed cell death protein
Externí odkaz:
https://doaj.org/article/f55e2218be274c9dae201de962674984
Autor:
Olga Tronina, Michał Brzdęk, Dorota Zarębska-Michaluk, Dorota Dybowska, Beata Lorenc, Ewa Janczewska, Włodzimierz Mazur, Anna Parfieniuk-Kowerda, Anna Piekarska, Rafał Krygier, Jakub Klapaczyński, Hanna Berak, Jerzy Jaroszewicz, Aleksander Garlicki, Krzysztof Tomasiewicz, Jolanta Citko, Robert Flisiak
Publikováno v:
Viruses, Vol 15, Iss 3, p 677 (2023)
Direct-acting antivirals (DAA) regimens have provided hope for eliminating hepatitis C virus (HCV) infection. Patients following ineffective therapy with DAA, especially those previously treated with inhibitors of non-structural protein 5A (NS5A), re
Externí odkaz:
https://doaj.org/article/f76918a6d9b84ca3a68b0e5269e09f90
Autor:
Dorota Zarębska-Michaluk, Anna Piekarska, Jerzy Jaroszewicz, Jakub Klapaczyński, Marek Sitko, Magdalena Tudrujek-Zdunek, Krzysztof Tomasiewicz, Teresa Belica-Wdowik, Paweł Pabjan, Beata Lorenc, Agnieszka Czauż-Andrzejuk, Olga Tronina, Rafał Krygier, Witold Dobracki, Iwona Buczyńska, Krzysztof A. Simon, Dorota Dybowska, Waldemar Halota, Małgorzata Pawłowska, Jolanta Citko, Łukasz Laurans, Włodzimierz Mazur, Ewa Janczewska, Łukasz Socha, Zbigniew Deroń, Hanna Berak, Robert Flisiak
Publikováno v:
Archives of Medical Science, Vol 18, Iss 6, Pp 1460-1466 (2019)
Introduction Non-cirrhotic treatment-naive hepatitis C patients infected with genotype 1 can be treated with ledipasvir/sofosbuvir (LDV/SOF) for 8 weeks, but in practice this regimen is frequently extended up to 12 weeks at least in part due to insuf
Externí odkaz:
https://doaj.org/article/98c74331a41c48fab58d3002fa6f0ffa
Autor:
Michał Brzdęk, Dorota Zarębska-Michaluk, Piotr Rzymski, Beata Lorenc, Adam Kazek, Magdalena Tudrujek-Zdunek, Justyna Janocha-Litwin, Włodzimierz Mazur, Dorota Dybowska, Hanna Berak, Anna Parfieniuk-Kowerda, Jakub Klapaczyński, Marek Sitko, Barbara Sobala-Szczygieł, Anna Piekarska, Robert Flisiak
Publikováno v:
World Journal of Gastroenterology. 29:2015-2033
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa5b9741916ac5b8ada618b7a0ed4ef1
https://doi.org/10.3748/wjg.v29.i13.2015
https://doi.org/10.3748/wjg.v29.i13.2015
Autor:
Ewa Janczewska, Dorota Zarębska-Michaluk, Hanna Berak, Anna Piekarska, Andrzej Gietka, Dorota Dybowska, Włodzimierz Mazur, Teresa Belica-Wdowik, Witold Dobracki, Magdalena Tudrujek-Zdunek, Zbigniew Deroń, Iwona Buczyńska, Marek Sitko, Agnieszka Czauż-Andrzejuk, Beata Lorenc, Jolanta Białkowska-Warzecha, Jolanta Citko, Łukasz Laurans, Jerzy Jaroszewicz, Łukasz Socha, Olga Tronina, Brygida Adamek, Andrzej Horban, Waldemar Halota, Barbara Baka-Ćwierz, Krzysztof Tomasiewicz, Krzysztof Simon, Aleksander Garlicki, Marta Wawrzynowicz-Syczewska, Robert Flisiak
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background According to the EASL and AASLD guidelines, the recommended treatment for patients who failed to achieve a sustained virologic response (SVR) on prior interferon-based triple therapy with protease inhibitors (PI), is a combination
Externí odkaz:
https://doaj.org/article/f74922258b364284bf1043b0ac680f8f
Autor:
Flisiak, Monika Pazgan-Simon, Jerzy Jaroszewicz, Krzysztof Simon, Beata Lorenc, Marek Sitko, Dorota Zarębska-Michaluk, Dorota Dybowska, Magdalena Tudrujek-Zdunek, Hanna Berak, Włodzimierz Mazur, Jakub Klapaczyński, Ewa Janczewska, Anna Parfieniuk-Kowerda, Robert
Publikováno v:
Journal of Personalized Medicine; Volume 13; Issue 7; Pages: 1111
Introduction: In Poland, active HCV infection affects between 0.4 and 0.5% of the population, i.e., about 150,000 people, while the number of patients with epilepsy is estimated to be 350,000–400,000. Currently available antiviral therapies show li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::14031d85f812130e9d1e70f4f6d6c884
Autor:
Dorota Zarębska-Michaluk, Michał Brzdęk, Jerzy Jaroszewicz, Magdalena Tudrujek-Zdunek, Beata Lorenc, Jakub Klapaczyński, Włodzimierz Mazur, Adam Kazek, Marek Sitko, Hanna Berak, Justyna Janocha-Litwin, Dorota Dybowska, Łukasz Supronowicz, Rafał Krygier, Jolanta Citko, Anna Piekarska, Robert Flisiak
Publikováno v:
World journal of gastroenterology. 28(45)
The revolution in treatment of patients with chronic hepatitis C virus (HCV) infection dates back to the introduction of direct-acting antivirals (DAAs). The increase in efficacy was most pronounced in patients infected with genotype (GT) 1b, as this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8438cb6191b094e9b29a32880ee8bfae
https://pubmed.ncbi.nlm.nih.gov/36533109
https://pubmed.ncbi.nlm.nih.gov/36533109
Autor:
Paweł Rajewski, Dorota Zarębska-Michaluk, Ewa Janczewska, Andrzej Gietka, Włodzimierz Mazur, Magdalena Tudrujek-Zdunek, Krzysztof Tomasiewicz, Teresa Belica-Wdowik, Barbara Baka-Ćwierz, Dorota Dybowska, Waldemar Halota, Beata Lorenc, Marek Sitko, Aleksander Garlicki, Hanna Berak, Andrzej Horban, Iwona Orłowska, Krzysztof Simon, Łukasz Socha, Marta Wawrzynowicz-Syczewska, Jerzy Jaroszewicz, Zbigniew Deroń, Agnieszka Czauż-Andrzejuk, Jolanta Citko, Rafał Krygier, Anna Piekarska, Łukasz Laurans, Witold Dobracki, Jolanta Białkowska, Olga Tronina, Magdalena Wietlicka-Piszcz, Małgorzata Pawłowska, Robert Flisiak
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 17; Pages: 5193
Hepatitis C infection is one of the main reasons for liver cirrhosis and hepatocellular carcinoma. In recent years, more and more is being heard about extrahepatic manifestations of the hepatitis C infection including its possible influence on the de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d40a5750958c7bd8ac46659b155a3e8
https://pubmed.ncbi.nlm.nih.gov/36079122
https://pubmed.ncbi.nlm.nih.gov/36079122
Autor:
Zbigniew Deroń, Łukasz Laurans, Krzysztof Simon, Rafał Krygier, Jolanta Białkowska-Warzecha, Jolanta Citko, Ewa Janczewska, Dorota Dybowska, Beata Dobracka, Jerzy Jaroszewicz, Iwona Buczyńska, Małgorzata Pawłowska, Olga Tronina, Marek Sitko, Brygida Adamek, Anna Piekarska, Krzysztof Tomasiewicz, Beata Lorenc, Magdalena Tudrujek-Zdunek, Łukasz Socha, Robert Flisiak, Agnieszka Czauż-Andrzejuk, Włodzimierz Mazur, Dorota Zarębska-Michaluk, Mateusz Franciszek Kołek, Jakub Klapaczyński, Waldemar Halota, Hanna Berak
Publikováno v:
World Journal of Gastroenterology
Background The introduction of direct-acting antiviral drugs into clinical practice has revolutionized the treatment of chronic hepatitis C, making it highly effective and safe for patients. However, few researchers have analyzed the factors causing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38b0f9e8ab95913aae58a23daf64feb8
https://doi.org/10.3748/wjg.v27.i18.2177
https://doi.org/10.3748/wjg.v27.i18.2177